News und Analysen
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
Price is sometimes an indicator of quality, whether on equity markets or elsewhere. But just because a stock has a low sticker price doesn't mean it isn't worth considering. Investors can find
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: GN Store Nord A/S announces successful completion of directed issue and private placing of new shares and existing treasury shares, raising gross proceeds of approximately DKK 2.75 bn
Why Shares of Organogenesis Climbed Wednesday
Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and
2 Under-the-Radar Biotech Stocks to Buy in 2023
There are reasons to be wary of the stock market right now. Chief among them is the fact that the economy continues to be somewhat uncertain, making it difficult to predict how things will develop
EQS-Adhoc: GN Store Nord A/S announces plan to strengthen its capital structure to execute growth opportunities including a directed issue and private placing of a total of approximately 17 million shares
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Integra LifeSciences Stock Is Crashing Today
Shares of Integra LifeSciences (NASDAQ: IART) were crashing on Tuesday, with the stock falling 20.7% as of 3:39 p.m. ET. The steep decline came after the company revealed in a regulatory filing that
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Catalent Stock Could Only Inch Higher Today
Catalent (NYSE: CTLT) investors are clearly an optimistic bunch, as lately they've been taking not-so-bad-news very positively and trading up the stock. This dynamic was clearly in force on Monday
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Shares of Catalent Were Up Friday
Shares of contract drug manufacturer Catalent (NYSE: CTLT) were up more than 14% Friday afternoon after the healthcare company announced updated guidance and said it was delaying its third-quarter
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
It's Cheap and Pays a Big Dividend, But Is Viatris Stock a Buy?
Companies that produce generic drugs aren't known for being exciting investments, and there's little chance they'll ever expand as fast as your average tech stock or most other growth stocks. If
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: MorphoSys AG Reports Outcome of Annual General Meeting 2023
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Better Growth Stock: Tilray vs. Green Thumb Industries
Investing in the cannabis industry is tricky. Some investors may be tempted to entirely shun the space based on its performance over the last two years. However, a few companies still offer
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Acadia Healthcare Names Judith Scimone Company’s New Chief Human Resources Officer
Acadia Healthcare Company Inc. (NASDAQ: ACHC) today announced that Judith Scimone has joined Acadia as the Company’s Chief Human Resources Officer (CHRO). In this role, she will shape and advance
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Shares of Cassava Sciences Jumped This Week
Shares of Cassava Sciences (NASDAQ: SAVA) were up 18.7% for the week, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech stock closed at $22.32 last week, then